Genetic Profiling of α1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130
- 1 May 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 63 (5) , 1104-1116
- https://doi.org/10.1124/mol.63.5.1104
Abstract
α1-Adrenoceptor subtypes (α1A-, α1B-, α1D-) are known to couple to similar signaling pathways, although differences among the subtypes do exist. As a more sensitive assay, we used oligonucleotide microarrays to identify gene expression changes in Rat-1 fibroblasts stably expressing each individual subtype. We report the gene expressions that change by at least a factor of 2 or more. Gene expression profiles significantly changed equally among all three subtypes, despite the unequal efficacy of the inositol phosphate response. Gene expressions were clustered into cytokines/growth factors, transcription factors, enzymes, and extracellular matrix proteins. There were also a number of individual subtype-specific changes in gene expression, suggesting a link to independent pathways. In addition, all three α1-AR subtypes robustly stimulated the transcription of the prohypertrophic cytokine interleukin (IL)-6, but differentially altered members of the IL-6 signaling pathway (gp-130 and STAT3). This was confirmed by measurement of secreted IL-6, activated STAT3, and gp-130 levels. Activation of STAT3 Tyr705 phosphorylation by the α1-ARs was not through IL-6 activation but was synergistic with IL-6, suggesting direct effects. Interestingly, α1B-AR stimulation caused the dimerization-dependent phosphorylation of Tyr705 on STAT3 but did not activate the transcriptional-dependent phosphorylation of Ser727. The α1B-AR also constitutively down-regulated the protein levels of gp-130. These results suggest that the α1B-AR has differential effects on the phosphorylation status of the STAT3 pathway and may not be as prohypertrophic as the other two subtypes.Keywords
This publication has 51 references indexed in Scilit:
- Gene expression profiling of α1b-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arraysCardiovascular Research, 2003
- Mice expressing the α1B‐adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylationJournal of Neurochemistry, 2002
- How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 geneThe EMBO Journal, 2000
- Cardiovascular α1-adrenoceptor subtypes: functions and signalingCanadian Journal of Physiology and Pharmacology, 2000
- Cross-talk between α1B-Adrenergic Receptor (α1BAR) and Interleukin-6 (IL-6) Signaling PathwaysJournal of Biological Chemistry, 1999
- Cell type-specific Transcriptional Activation and Suppression of the α1B Adrenergic Receptor Gene Middle Promoter by Nuclear Factor 1Published by Elsevier ,1998
- Differential effects of adrenaline and noradrenaline on the hepatic expression of immediate early genes in miceJournal of Autonomic Pharmacology, 1998
- The Type I Angiotensin II Receptor Couples to Stat1 and Stat3 Activation Through Jak2 Kinase in Neonatal Rat Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1997
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Norepinephrine induces expression of c-fos mRNA through the α-adrenoceptor in rat aortic ringsCanadian Journal of Physiology and Pharmacology, 1995